In This Article:
Over the last 7 days, the United States market has dropped 2.6%, yet it remains up by 9.1% over the past year with earnings forecasted to grow by 14% annually. In this context, identifying high growth tech stocks involves looking for companies with strong innovation potential and robust financial health that align well with these positive long-term growth prospects despite short-term fluctuations.
Top 10 High Growth Tech Companies In The United States
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| Super Micro Computer | 26.38% | 39.09% | ★★★★★★ |
| Mereo BioPharma Group | 53.62% | 66.56% | ★★★★★★ |
| Ardelyx | 20.78% | 59.46% | ★★★★★★ |
| Travere Therapeutics | 26.41% | 64.47% | ★★★★★★ |
| TG Therapeutics | 26.46% | 38.75% | ★★★★★★ |
| Alnylam Pharmaceuticals | 23.65% | 61.11% | ★★★★★★ |
| AVITA Medical | 27.28% | 60.66% | ★★★★★★ |
| Alkami Technology | 20.54% | 76.67% | ★★★★★★ |
| Ascendis Pharma | 35.16% | 60.26% | ★★★★★★ |
| Lumentum Holdings | 21.59% | 110.32% | ★★★★★★ |
Click here to see the full list of 233 stocks from our US High Growth Tech and AI Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
LifeMD
Simply Wall St Growth Rating: ★★★★☆☆
Overview: LifeMD, Inc. is a direct-to-patient telehealth company facilitating connections between consumers and healthcare professionals for medical care in the United States, with a market cap of $524.01 million.
Operations: The company generates revenue primarily from its telehealth services, accounting for $180.05 million, and Worksimpli segment contributing $53.95 million.
LifeMD's strategic maneuvers, including its recent partnership with Novo Nordisk and integration with NovoCare Pharmacy, underscore its commitment to expanding access to weight management treatments. This collaboration not only enhances LifeMD's product offering but also solidifies its position in the telehealth market by providing a comprehensive care model from virtual consultations to prescription fulfillment. Financially, LifeMD has shown significant progress; Q1 2025 revenue surged to $65.7 million from $44.14 million year-over-year, and it flipped a net loss of $6.77 million into a net income of $1.38 million. Looking ahead, the company raised its full-year revenue forecast for 2025 to between $268 million and $275 million, reflecting confidence in continued growth driven by innovations in healthcare delivery and patient engagement strategies.
-
Click here to discover the nuances of LifeMD with our detailed analytical health report.
-
Assess LifeMD's past performance with our detailed historical performance reports.
Exodus Movement
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Exodus Movement, Inc. is a financial technology company focused on the blockchain and digital asset industry in the United States, with a market cap of $1.01 billion.